Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 538 (LINC00538), also known as Yiya or PROX1 upstream transcript, is a long non-coding RNA gene located upstream of the transcription factor PROX1. LINC00538 does not encode a protein but is implicated in the regulation of gene expression, possibly affecting cell fate and development. It has been found to promote papillary thyroid cancer progression by modulating the epithelial-mesenchymal transition (EMT) process and is considered an oncogenic long non-coding RNA in several cancer types[2][3]. LINC00538 may play a role in cell cycle progression and cell proliferation, with evidence also suggesting involvement in neurological disease contexts such as focal epilepsy[6]. Its precise mechanisms of action and therapeutic relevance are still under investigation, and there are currently no known drugs that directly target this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 538 (LINC00538).